Stockreport

Small Biotech Jumps On $100 Million Cancer Deal With Pharma Giant J&J [Investor's Business Daily]

Fate Therapeutics, Inc.  (FATE) 
Last fate therapeutics, inc. earnings: 3/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.fatetherapeutics.com/investor-relations
PDF Shares of Fate Therapeutics popped Friday after the biotech company announced a deal with Johnson & Johnson to develop cancer treatments in the immuno-oncology class of [Read more]